SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 197 filers reported holding SEATTLE GENETICS INC in Q1 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,539,000 | +24.2% | 18,020 | +0.7% | 2.78% | +51.7% |
Q2 2019 | $1,239,000 | -5.1% | 17,901 | +0.4% | 1.83% | +3.6% |
Q1 2019 | $1,306,000 | +20.5% | 17,832 | -6.8% | 1.77% | -25.8% |
Q4 2018 | $1,084,000 | -27.1% | 19,127 | -0.8% | 2.39% | -32.8% |
Q3 2018 | $1,487,000 | +7.5% | 19,288 | -7.4% | 3.55% | +18.4% |
Q2 2018 | $1,383,000 | +25.0% | 20,834 | -1.4% | 3.00% | +38.3% |
Q1 2018 | $1,106,000 | -42.0% | 21,126 | -40.8% | 2.17% | +31.5% |
Q4 2017 | $1,908,000 | -15.0% | 35,668 | -13.6% | 1.65% | -18.1% |
Q3 2017 | $2,245,000 | +23.6% | 41,263 | +17.6% | 2.01% | +21.0% |
Q2 2017 | $1,816,000 | -58.4% | 35,093 | -49.5% | 1.66% | -48.7% |
Q1 2017 | $4,370,000 | +21.2% | 69,512 | +1.8% | 3.24% | +12.9% |
Q4 2016 | $3,605,000 | -1.8% | 68,310 | +0.5% | 2.87% | +39.6% |
Q3 2016 | $3,670,000 | +22.6% | 67,953 | -8.3% | 2.06% | -28.8% |
Q2 2016 | $2,994,000 | -22.4% | 74,093 | -32.6% | 2.89% | -3.0% |
Q1 2016 | $3,857,000 | -32.4% | 109,922 | -13.5% | 2.98% | -20.9% |
Q4 2015 | $5,704,000 | +18.8% | 127,088 | +2.0% | 3.77% | +42.1% |
Q3 2015 | $4,803,000 | -4.9% | 124,558 | +19.4% | 2.65% | -33.7% |
Q2 2015 | $5,050,000 | +28.6% | 104,339 | -6.0% | 4.00% | +21.6% |
Q1 2015 | $3,926,000 | +48.6% | 111,050 | +35.0% | 3.29% | +25.9% |
Q4 2014 | $2,642,000 | – | 82,253 | – | 2.61% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |